These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 32447044)
21. The challenge of long-term follow-up of survivors of childhood acute leukemia after hematopoietic stem cell transplantation in resource-limited countries: A single-center report from Brazil. Marinho DH; Ribeiro LL; Nichele S; Loth G; Koliski A; Mousquer RTG; Funke VAM; Page K; Fasth A; Pasquini R; Boguszewski MCDS; Bonfim C Pediatr Transplant; 2020 Jun; 24(4):e13691. PubMed ID: 32246550 [TBL] [Abstract][Full Text] [Related]
22. Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties. Uderzo C; Pillon M; Corti P; Tridello G; Tana F; Zintl F; Nysom K; Galambrun C; Fagioli F; Varotto S; Messina C; Verdeguer A; Urban C; Faraci M; Dini G; Fedeli S; Tichelli A; Rovelli A; Socié G Bone Marrow Transplant; 2007 Jun; 39(11):667-75. PubMed ID: 17401396 [TBL] [Abstract][Full Text] [Related]
23. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease. Atsuta Y; Suzuki R; Yamashita T; Fukuda T; Miyamura K; Taniguchi S; Iida H; Uchida T; Ikegame K; Takahashi S; Kato K; Kawa K; Nagamura-Inoue T; Morishima Y; Sakamaki H; Kodera Y; Ann Oncol; 2014 Feb; 25(2):435-41. PubMed ID: 24399081 [TBL] [Abstract][Full Text] [Related]
24. Differences in Graft-versus-Host Disease Characteristics between Haploidentical Transplantation Using Post-Transplantation Cyclophosphamide and Matched Unrelated Donor Transplantation Using Calcineurin Inhibitors. Solh MM; Baron J; Zhang X; Bashey A; Morris LE; Holland HK; Solomon SR Biol Blood Marrow Transplant; 2020 Nov; 26(11):2082-2088. PubMed ID: 32745575 [TBL] [Abstract][Full Text] [Related]
25. Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial. Locatelli F; Bernardo ME; Bertaina A; Rognoni C; Comoli P; Rovelli A; Pession A; Fagioli F; Favre C; Lanino E; Giorgiani G; Merli P; Pagliara D; Prete A; Zecca M Lancet Oncol; 2017 Aug; 18(8):1126-1136. PubMed ID: 28705454 [TBL] [Abstract][Full Text] [Related]
26. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor. Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917 [TBL] [Abstract][Full Text] [Related]
27. Long-term thyroid disorders in pediatric survivors of hematopoietic stem cell transplantation after chemotherapy-only conditioning. Cima LN; Martin SC; Lambrescu IM; Stejereanu L; Zaharia C; Colita A; Fica S J Pediatr Endocrinol Metab; 2018 Aug; 31(8):869-878. PubMed ID: 29935114 [TBL] [Abstract][Full Text] [Related]
28. Gonadal Failure Is Common in Long-Term Survivors of Childhood High-Risk Neuroblastoma Treated With High-Dose Chemotherapy and Autologous Stem Cell Rescue. Utriainen P; Suominen A; Mäkitie O; Jahnukainen K Front Endocrinol (Lausanne); 2019; 10():555. PubMed ID: 31440211 [No Abstract] [Full Text] [Related]
29. Ovarian function after allogeneic hematopoietic stem cell transplantation in childhood and adolescence. Vatanen A; Wilhelmsson M; Borgström B; Gustafsson B; Taskinen M; Saarinen-Pihkala UM; Winiarski J; Jahnukainen K Eur J Endocrinol; 2014 Feb; 170(2):211-8. PubMed ID: 24179099 [TBL] [Abstract][Full Text] [Related]
30. Ovarian insufficiency and pubertal development after hematopoietic stem cell transplantation in childhood. Bresters D; Emons JA; Nuri N; Ball LM; Kollen WJ; Hannema SE; Bakker-Steeneveld JD; van der Bom JG; Oostdijk W Pediatr Blood Cancer; 2014 Nov; 61(11):2048-53. PubMed ID: 25111958 [TBL] [Abstract][Full Text] [Related]
31. Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" Study. Choi JK; Cho SY; Yoon SS; Moon JH; Kim SH; Lee JH; Kim JS; Cheong JW; Jang JH; Seo BJ; Kim YJ; Lee HJ; Lee J; Lee JW; Lee DG Biol Blood Marrow Transplant; 2017 Oct; 23(10):1773-1779. PubMed ID: 28668492 [TBL] [Abstract][Full Text] [Related]
32. Frequent occurrence of cytomegalovirus retinitis during immune reconstitution warrants regular ophthalmic screening in high-risk pediatric allogeneic hematopoietic stem cell transplant recipients. Hiwarkar P; Gajdosova E; Qasim W; Worth A; Breuer J; Chiesa R; Ridout D; Edelsten C; Moore A; Amrolia P; Veys P; Rao K Clin Infect Dis; 2014 Jun; 58(12):1700-6. PubMed ID: 24700657 [TBL] [Abstract][Full Text] [Related]
33. Secondary failure of platelet recovery after hematopoietic stem cell transplantation. Bruno B; Gooley T; Sullivan KM; Davis C; Bensinger WI; Storb R; Nash RA Biol Blood Marrow Transplant; 2001; 7(3):154-62. PubMed ID: 11302549 [TBL] [Abstract][Full Text] [Related]
34. Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results. Kebriaei P; Bassett R; Lyons G; Valdez B; Ledesma C; Rondon G; Oran B; Ciurea S; Alousi A; Popat U; Patel K; Ahmed S; Olson A; Bashir Q; Shah N; Jones R; Marin D; Rezvani K; Nieto Y; Khouri I; Qazilbash M; Hosing C; Shpall E; Champlin RE; Andersson BS Biol Blood Marrow Transplant; 2017 Feb; 23(2):285-292. PubMed ID: 27816651 [TBL] [Abstract][Full Text] [Related]
35. Neurologic complications after allogeneic hematopoietic stem cell transplantation in children: analysis of prognostic factors. Kang JM; Kim YJ; Kim JY; Cho EJ; Lee JH; Lee MH; Lee SH; Sung KW; Koo HH; Yoo KH Biol Blood Marrow Transplant; 2015 Jun; 21(6):1091-8. PubMed ID: 25708217 [TBL] [Abstract][Full Text] [Related]
36. Adolescent male fertility following reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in non-malignant disorders. Zhao J; Beebe K; Magee K; Salzberg D; Stahlecker J; Miller HK; Adams RH; Lipskind S; Walsh A; Mirea L; Ngwube A Pediatr Transplant; 2019 Sep; 23(6):e13496. PubMed ID: 31124253 [TBL] [Abstract][Full Text] [Related]
37. Patterns of Genital Examination and Vulvovaginal Graft-Versus-Host Disease in a Pediatric Post-Hematopoietic Stem Cell Transplant Population. Allen SM; Liang CS; Chesnokova AE; Childress KJ; Pascoe KF; Dietrich JE J Pediatr Adolesc Gynecol; 2020 Dec; 33(6):658-666. PubMed ID: 32781233 [TBL] [Abstract][Full Text] [Related]
38. Transplantation-related mortality, graft failure, and survival after reduced-toxicity conditioning and allogeneic hematopoietic stem cell transplantation in 100 consecutive pediatric recipients. Satwani P; Jin Z; Duffy D; Morris E; Bhatia M; Garvin JH; George D; Bradley MB; Harrison L; Petrillo K; Schwartz J; Foley S; Hawks R; Baxter-Lowe LA; Cairo MS Biol Blood Marrow Transplant; 2013 Apr; 19(4):552-61. PubMed ID: 23253557 [TBL] [Abstract][Full Text] [Related]
39. Chronic graft-versus-host disease and late effects after hematopoietic stem cell transplantation. Sanders JE Int J Hematol; 2002 Aug; 76 Suppl 2():15-28. PubMed ID: 12430895 [TBL] [Abstract][Full Text] [Related]
40. HLA, GVHD, and parenteral nutrition are risk factors for hepatic complications in pediatric HSCT. Thorvaldson L; Remberger M; Winiarski J; Omazic B; Fischler B; Sundin M Pediatr Transplant; 2016 Feb; 20(1):96-104. PubMed ID: 26518451 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]